Skip to content
Search

Latest Stories

Bangor University greenlights new Pharmacy degree for September 2025; support regional health and wellbeing

Bangor University greenlights new Pharmacy degree for September 2025; support regional health and wellbeing
As Bangor University expands its Medical School, it adds a new Pharmacy degree aimed to provide local students with opportunities to meet healthcare demands

In latest updates, Bangor University has given the go-ahead for a new pharmacy degree starting September 2025.

The four-year Master of Pharmacy( MPharm)undergraduate degree programme is the primary route that students take to become pharmacists and will be offered in Welsh language.


The programme is part of the institution's strategy to provide opportunities for local applicants encouraging them to pursue vital fields and ensure they meet the healthcare workforce demands in North Wales and beyond.

The new provisionally GPhC-approved MPharm degree, set to open registrations for the September-intake, is under the new North Wales Medical School and offers Pharmacy alongside Medicine and allied Health programmes.

The programme will be provisionally accredited until the accreditation process is complete.

Aligning with the GPhC’s new Standards for Initial Education and Training of Pharmacists, the MPharm programme aims to support the regional health and wellbeing of the population by preparing pharmacy graduates as part of integrated healthcare teams to facilitate patient care.

Bangor University offers significant experiential teaching through partnerships with the Betsi Cadwaladr University Health Board (BCUHB), community pharmacies, GP practices, and Health Education and Improvement Wales (HEIW).

Moreover, in partnership with BCUHB, Bangor University aims to be the foremost provider of quality pharmacy education in North Wales.

According to the University, stakeholder involvement is central to the philosophy of the MPharm programme structure.

With core pillars focusing on The Patient, The Pharmacist, and The Health Care System, these will be integrated into ‘Patients, their Medicines and their Care (PMC)’ modules that students will follow.

Prof Stephen Doughty, Head of Pharmacy Programme at Bangor University, said, “This programme will meet both a local and national need and will ensure that North Wales has a strong base for pharmacy education and research.

"This will ensure that patients and potential students’ needs are being met for the future.”

Lois Lloyd, Chief Pharmacist at Betsi Cadwaladr University Health Board, said: “I’m delighted with this positive news for North Wales and we look forward to working in partnership with Bangor University to support the programme.

"We now have an opportunity to locally invest in the training of pharmacists in North Wales and to develop the clinically skilled workforce we, and the wider NHS, need for the future.”

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less